{"name":"Medistem Inc.","slug":"medistem-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Administration of ERC","genericName":"Administration of ERC","slug":"administration-of-erc","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Administration of ERC","genericName":"Administration of ERC","slug":"administration-of-erc","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxOVXQ5N1MtVlFrcFA0MzlRUW84TUVfY3BrcVZRU3dHaU8yUzhMbC1pTktjNGMwY3g1Qzl0VVJ2VFN1OEc0WFhEb2hDYjVrOUlCeUdZRmdCNHdZaUR5RUQzOUU5OGxQOGVGcGZmNkFNRkNvQUpIdlVoU3dFZnFDRTJEU2hYQTRrd3ZfZ1F2bGhRQTducjZyMnluM2EzU1NLRkZDU180Q1NFVVlPaVFhRVZoY0E0UFRsUGJoUTZZRnc5RHJrTUtTWlROUUNaWDROMnI4WWlweDAtUllJblhDeTJnQmpYeTV4eWxLTkcwcU41VQ?oc=5","date":"2023-03-27","type":"pipeline","source":"businesswire.com","summary":"Biotechnology Veteran Dr. Thomas Ichim to Lead Suicide Prediction Company Campbell Neurosciences, Inc. - businesswire.com","headline":"Biotechnology Veteran Dr. Thomas Ichim to Lead Suicide Prediction Company Campbell Neurosciences, Inc.","sentiment":"neutral"},{"date":"2014-01-31","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT ON FORM 8-K","headline":"SEC 8-K: CURRENT REPORT ON FORM 8-K","sentiment":"neutral"},{"date":"2014-01-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2013-12-30","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC: SCHEDULE 13D","headline":"SC 13D Filing","sentiment":"neutral"},{"date":"2013-12-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2013-11-12","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: QUARTERLY REPORT","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":null,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":null,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}